ALRNAILERON THERAPEUTICS INC

Nasdaq aileronrx.com


$ 2.15 $ 0.26 (13.76 %)    

Monday, 19-Aug-2024 15:59:26 EDT
QQQ $ 481.15 $ 6.24 (1.31 %)
DIA $ 409.09 $ 2.37 (0.58 %)
SPY $ 559.11 $ 5.30 (0.96 %)
TLT $ 97.90 $ 0.45 (0.46 %)
GLD $ 231.62 $ -0.38 (-0.16 %)
$ 2.15
$ 2.11
$ 2.04 x 100
$ 2.15 x 100
$ 2.01 - $ 2.15
$ 1.01 - $ 7.42
59,450
na
42.81M
$ 1.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 04-15-2024 12-31-2023 10-K
4 10-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-20-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
14 05-11-2021 03-31-2021 10-Q
15 03-24-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-30-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-08-2019 03-31-2019 10-Q
23 03-29-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 02-14-2013 12-31-2012 10-Q
31 11-14-2012 09-30-2012 10-Q
32 08-13-2012 06-30-2012 10-Q
33 06-22-2012 03-31-2012 10-K
34 02-14-2012 12-31-2011 10-Q
35 11-14-2011 09-30-2011 10-Q
36 08-12-2011 06-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aileron-therapeutics-q2-2024-gaap-eps-045-misses-042-estimate-cash-position-219m

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate o...

 aileron-therapeutics-got-into-equity-distribution-agreement-may-offer--sell-shares-of-our-common-stock-from-time-to-time-of-up-to-50m

- SEC Filing

 aileron-therapeutics-included-in-the-russell-microcap-index

Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ:ALRN), a biopharmaceutical company advancing a ...

 aileron-therapeutics-q1-2024-gaap-eps-086-misses-014-estimate

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate o...

 aileron-therapeutics-announces-data-from-cohort-1-of-phase-1b-clinical-trial-of-lti-03-in-idiopathic-pulmonary-fibrosis

Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both patholo...

 aileron-therapeutics-filed-us-patent-application-20240124518-methods-for-preparing-purified-polypeptide-compositions

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240124518

 ladenburg-thalmann-maintains-buy-on-aileron-therapeutics-raises-price-target-to-19

Ladenburg Thalmann analyst Aydin Huseynov maintains Aileron Therapeutics (NASDAQ:ALRN) with a Buy and raises the price targe...

 aileron-therapeutics-q4-eps-154-down-from-100-yoy-cash-runway-expected-to-fund-operations-and-key-milestones-into-q4-of-2024

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(1.54) per share versus losses of $(1.00) per share from the s...

 on-feb-29-aileron-therapeutics-got-letter-from-nasdaq-that-co-has-regained-compliance-for-continued-listing-on-nasdaq

- SEC Filing

 aileron-therapeutics-and-pulmonary-care-experts-to-discuss-the-potential-implications-of-lti-03-for-idiopathic-pulmonary-fibrosis-in-virtual-key-opinion-leader-event

Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:ALRN), a biopharmaceutical company advancing a novel pipeline of first-i...

 why-ups-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-e...

 why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

 why-getaround-shares-are-trading-higher-by-around-86-here-are-20-stocks-moving-premarket

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increas...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION